Juni 2008
Sloning establishes a North American business & technology team
April 2008
Sloning and the Kornberg group at Stanford University starting evaluation project.
Learn more about SlonoMax™ libraries or SlonoGene™ services, both based on our Slonomics® platform direct from this website:
SlonoMax™ mutant libraries for biopharmaceuticals
SlonoMax™ mutant libraries for industrial biotechnology
Request your Genes Online: SlonoGene™
Welcome
Sloning BioTechnology GmbH specializes in the production of highly genetically diverse and precise customized libraries. We offer high quality, innovative, tailored protein engineering solutions to our industrial and biopharmaceutical customers worldwide.
Our core technology is Slonomics®, a unique DNA engineering platform using defined sets of double stranded DNA triplets. We use Slonomics® to synthesize SlonoMax™ libraries (customized gene mutant libraries) for our customers that significantly enhance the screening for new and improved therapeutic proteins or proteins used in technical applications.
In addition, using our Slonomics® platform we also offer a premium gene synthesis service for our industrial clients. SlonoGene™ is a tailored service offering gene customization and optimization suited perfectly to the needs of our customers.
